DEF 14A

Company

Dermata Therapeutics, Inc.

Filed

March 26, 2024

Period of Report

March 5, 2024

Accession Number

0001654954-24-003656

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →